Details van artikel 488 van 619 gevonden artikelen
2 Safety and early evidence of activity of a first-in-human phase I study of the novel cancer stem cell (CSC) targeting antibody OMP-52M51 (anti-Notch1) administered intravenously to patients with certain advanced solid tumors
Titel:
2 Safety and early evidence of activity of a first-in-human phase I study of the novel cancer stem cell (CSC) targeting antibody OMP-52M51 (anti-Notch1) administered intravenously to patients with certain advanced solid tumors
Auteur:
Patnaik, A. LoRusso, P. Munster, P. Tolcher, A.W. Davis, S.L. Heymach, J. Ferraroto, R. Xu, L. Kapoun, A.M. Faoro, L. Lewicki, J.A. Dupont, J. Eckhardt, S.G.
Verschenen in:
European journal of cancer
Paginering:
Jaargang 50 (2014) nr. S6 pagina's 1 p.
Jaar:
2014
Inhoud:
Uitgever:
European Association for Cancer Research
Bronbestand:
Elektronische Wetenschappelijke Tijdschriften
Details van artikel 488 van 619 gevonden artikelen